Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer
- 31 December 2004
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 78 (6), 1903-1909
- https://doi.org/10.1016/j.athoracsur.2004.06.102
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and ControlJNCI Journal of the National Cancer Institute, 2003
- Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose UseJournal of Clinical Oncology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer, 1999
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerLung Cancer, 1998
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993